Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers

被引:141
作者
McFarlane, SI
Jacober, SJ
Winer, N
Kaur, J
Castro, JP
Wui, MA
Gliwa, A
Von Gizycki, H
Sowers, JR
机构
[1] SUNY Hlth Sci Ctr, Dept Med, Div Endocrinol Diabet & Hypertens, Brooklyn, NY 11203 USA
[2] SUNY Hlth Sci Ctr, Dept Cell Biol, Div Endocrinol Diabet & Hypertens, Brooklyn, NY 11203 USA
[3] Kings Cty Hosp Ctr, Brooklyn, NY USA
[4] VA Med Ctr Brooklyn, Brooklyn, NY USA
[5] Wayne State Univ, Detroit, MI USA
[6] VA Med Ctr, Detroit, MI USA
关键词
D O I
10.2337/diacare.25.4.718
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - There are national mandates to reduce blood pressure (BP) to <130/85 mmHg, LDL cholesterol to <100 mg/dl, and HbA(1c) to <7% and to institute aspirin therapy in patients with diabetes. The objective of this study was to determine the proportion of patients in urban institutions with diabetes and hypertension who meet these treatment goals. RESEARCH DESIGN AND METHODS - Using American Diabetes Association (ADA) guidelines, we evaluated the control of cardiovascular disease (CVD) risk factors in 1,372 patients receiving medical care at two major urban medical centers in Brooklyn and Detroit. Information was extracted from charts of outpatient clinics. RESULTS - Of 1,372 active clinic patients with diabetes and hypertension, 1,247 (90.9%) had type 2 diabetes, and 26.7% met the target blood pressure of 130/85 mmHg. A total of 35.5% met the goal LDL cholesterol level of < 100 mg/dl, 26.7% had an HbA(1c) <7%, and 45.6% were on antiplatelet therapy Only 3.2% of patients met the combined ADA goal for BP, LDL cholesterol, and HbA(1c). CONCLUSIONS - Optimal control of CVD risk factors in adults with diabetes was achieved only in a minority of patients. Results reflect the inherent difficulties in achieving these complex guidelines in our present health care systems.
引用
收藏
页码:718 / 723
页数:6
相关论文
共 36 条
[1]  
*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS58
[2]  
*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS33
[3]  
*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS62
[4]  
*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS64
[5]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[6]  
[Anonymous], 2002, Diabetes care, V25, pS1
[7]  
Bakris George L., 1999, J Clin Hypertens (Greenwich), V1, P141
[8]   Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661
[9]   Risk factors for stroke in type 2 diabetes mellitus - United Kingdom prospective diabetes study (UKPDS) 29 [J].
Davis, TME ;
Millns, H ;
Stratton, IM ;
Holman, RR ;
Turner, RC .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) :1097-1103
[10]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622